By Ben Hirschler LONDON (Reuters) - New research has nearly doubled the number of genetic variations implicated in breast, prostate and ovarian cancer, offering fresh avenues for screening at-risk patients and, potentially, developing better drugs. The bumper haul of 74 gene changes that can increase risks for the three hormone-related cancers, announced by scientists on Wednesday, is the result of the largest ever study of its kind. ...
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment